You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
King-jones Heidy · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$243K
King-jones Heidy See Remarks
SYRE
Spyre Therapeutics
SYRE
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
SYRE daily price context
Close on/before transaction
$89.93
Oct 1, 2026
First close after public filing
$92.72
Oct 5, 2026
30-day return after filing
+3.01%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,600 shares @ $93.46
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000119
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$3.05M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Exercise | Oct 1, 2026 | $419.53K |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Oct 1, 2026 | $243K |
| Spyre Therapeutics, Inc. SYRE | Sale | Oct 1, 2026 | $660.28K |
| Spyre Therapeutics, Inc. SYRE | Sale | Oct 1, 2026 | $35.7K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Oct 1, 2026 | $0 |
| Spyre Therapeutics, Inc. SYRE | Sale | Oct 1, 2026 | $194.67K |
| Spyre Therapeutics, Inc. SYRE | Sale | Oct 1, 2026 | $1.5M |